The Cooper Companies, Inc. (COO)
After hours:
| Previous Close | 340.25 |
| Open | 335.65 |
| Bid | 0.00 x 800 |
| Ask | 535.00 x 1100 |
| Day's Range | 332.92 - 338.80 |
| 52 Week Range | 309.43 - 463.59 |
| Volume | |
| Avg. Volume | 320,913 |
| Market Cap | 16.455B |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | 17.72 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.06 (0.02%) |
| Ex-Dividend Date | Jan 20, 2022 |
| 1y Target Est | N/A |
- News Direct
CooperCompanies Releases 2021 Environmental, Social, and Governance Highlights Report; Signs on to United Nations Global Compact
CooperCompanies has published its 2021 Environmental, Social, and Governance (ESG) Highlights Report, sharing the Company’s progress on ESG items most important to its businesses and stakeholders, ...
- GlobeNewswire
CooperCompanies to Participate in the Jefferies Healthcare Conference
SAN RAMON, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 9, 2022. Al White, President and CEO, will represent the Company in a session scheduled to begin at 1:00 PM ET. This webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A webcast replay will be available approximately 48 hours after the live webcast. Ab
- GlobeNewswire
Aspira Women’s Health Reports First Quarter 2022 Financial Results
Product Revenue Increased 30% to $1.8 million; OVA1plus Volume Grew 28% to 4,819 Units New Ordering Physicians in the First Quarter Grew 47% to 603 Year Over Year Board and Leadership appointments announced Conference Call and Webcast scheduled for today, May 11th at 8:30 a.m. ET AUSTIN, Texas, May 11, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for
